Calidi Biotherapeutics (Calidi Biotherapeutics) Short-Term Capital Lease Obligation : $1.15 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Short-Term Capital Lease Obligation?

Calidi Biotherapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.15 Mil.

Calidi Biotherapeutics's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 ($1.06 Mil) to Dec. 2023 ($1.12 Mil) and increased from Dec. 2023 ($1.12 Mil) to Mar. 2024 ($1.15 Mil).

Calidi Biotherapeutics's annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($0.14 Mil) to Dec. 2022 ($0.12 Mil) but then increased from Dec. 2022 ($0.12 Mil) to Dec. 2023 ($1.12 Mil).

Calidi Biotherapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Calidi Biotherapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Short-Term Capital Lease Obligation Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.34

0.14

0.12

1.12

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial					-	1.03	1.06	1.12	1.15

Calidi Biotherapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Calidi Biotherapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024